News

Fragmos Chain, an innovative fintech company, is thrilled to announce the resounding success of its recent platform trial, conducted in partnership with a consortium of six leading investment banks across Europe, Asia, and North America. The trial, which took place in February and March 2024, marked a significant milestone in the evolution of post-trade processing …

Six Major Banks Successfully Trialed Fragmos Chain Platform, Initiating Automation for Uncleared OTC Derivatives, Setting the Stage to Tackle 66% of Operational Costs & Risks in a $250 Trillion Market Read More »

Fragmos Chain has initiated a collective trial involving over 10 leading investment banks, collectively representing a 30% market share among broker-dealers. The focus of this trial is the transformation of OTC derivatives processing. During a meeting sponsored by a major Investment Bank, these banks have acknowledged the increased efficiency, reduced risks, and substantial cost savings …

Initiation of a Collective Action involving over 10 leading Investment Banks Read More »

London, UK – November 22, 2022 – Today Finastra announced a collaboration with Fragmos Chain, a blockchain platform which digitalizes interactions between financial institutions, to provide Finastra customers with out-of-the-box integration with Finastra Summit, its over-the-counter (OTC) derivatives market solution. The API-first integration, via FusionFabric.cloud, enables banks globally to digitalize their OTC derivatives products to reduce the costs and risks …

Finastra onboards Fragmos Chain’s blockchain platform for the digitalization of over-the-counter derivatives post-trade Read More »

① To manage any kind of swap and any kind of event, we recently added 3 functionalities: Matching of events and cash-flows Complex features such as risk-free rates, cap/floors or non-deliverable currencies Basket underliers As the only ISDA CDM-native post-trade platform, we capitalize on CDM’s modularity to offer a broad variety of products. We are …

The scope of Fragmos Chain post-trade platform for OTC derivatives is extending Read More »

Our CEO was interviewed on B Smart TV on December 17, 2021

Why OTC Derivatives? Our CEO, Daniel Ivanier, was invited by R3 to talk at the CordaCon 2021. Key highlights: Post-trade costs are huge for OTC derivatives: $400 per trade (compared to $2 for listed derivatives) Processes are complex These products are heavily regulated 

At the Finance Innovation Webinar, “Open Innovation & Collaboration between businesses, software vendors and Fintechs”, held on June 30th, 2021, Laurence Arnold, Head of Innovation Management and Strategic Initiatives at AXA Investment Managers, answered to Daniel Ivanier. https://www.youtube.com/watch?v=DCW0CpzBMhI Laurence’s speech was in French, you will find below the English translation. “For an Asset Manager today, 3/4 …

AXA IM Laurence Arnold’s speech at 6/30/2021 Finance Innovation Webinar Read More »

Trading in off-exchange derivatives has long been the domain of specialist brokers – an intricate world of bespoke contracts, non-standard risk and valuation models, blighted by suboptimal settlement operations. However, a new breed of technology promises to deliver a unified process and accountability in stark contrast to the challenges of legacy processes, opening the asset …

Simplicity out of complexity – Bringing OTC Derivatives in from the cold Read More »